Four-year survival after trans-jugular intrahepatic porto-systemic shunt for veno-occlusive disease following autologous bone marrow transplantation

被引：6
作者：
Annaloro, C
Robbiolo, L
Pozzoli, E
Ibatici, A
Nicolini, A
Salerno, F
Deliliers, GL
机构：
[1] Osped Maggiore Milano, IRCCS, Dept Hematol, Bone Marrow Transplant Unit, I-20122 Milan, Italy
[2] Osped Maggiore Milano, IRCCS, Dept Radiol, I-20122 Milan, Italy
[3] Osped Maggiore Milano, IRCCS, Dept Internal Med, I-20122 Milan, Italy
[4] Osped Maggiore Milano, IRCCS, Liver Unit, I-20122 Milan, Italy
来源：
LEUKEMIA & LYMPHOMA | 2004年 / 45卷 / 07期
关键词：
veno-occlusive liver disease; bone marrow transplantation; trans-jugular intrahepatic portosystemic shunt;
D O I：
10.1080/10428190410001663626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Severe hepatic veno-occlusive disease is still a potentially lethal complication after bone marrow transplantation. We here report the case of a patient who developed liver veno-occlusive disease with severe hemodynamic dysfunction and was successfully treated by means of a trans-jugular intrahepatic portosystemic shunt. After three years, he is still disease-free with a functioning shunt and a normal laboratory liver pro. le. A trans-jugular intrahepatic portosystemic shunt is a treatment option that has been used in very few patients affected by hepatic veno-occlusive disease; its indications and timing remain to be established.
引用
收藏
页码：1485 / 1487
页数：3
相关论文
共 10 条
[1]   Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation [J].
Azoulay, D ;
Castaing, D ;
Lemoine, A ;
Hargreaves, GM ;
Bismuth, H .
BONE MARROW TRANSPLANTATION, 2000, 25 (09) :987-992
[2]   Avoiding hepatic veno-occlusive disease: what do we know and where are we going? [J].
Bearman, SI .
BONE MARROW TRANSPLANTATION, 2001, 27 (11) :1113-1120
[3]   Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients [J].
Bearman, SI ;
Lee, JL ;
Baron, AE ;
McDonald, GB .
BLOOD, 1997, 89 (05) :1501-1506
[4]   VENO-OCCLUSIVE DISEASE OF THE LIVER AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - POSSIBLE ASSOCIATION WITH GRAFT VERSUS HOST DISEASE [J].
BERK, PD ;
POPPER, H ;
KRUEGER, GRF ;
DECTER, J ;
HERZIG, G ;
GRAW, RG .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (02) :158-164
[5]   Transjugular intrahepatic portosystemic shunt: Current status [J].
Boyer, TD .
GASTROENTEROLOGY, 2003, 124 (06) :1700-1710
[6]  
Carreras E, 1998, BLOOD, V92, P3599
[7]   LIVER-DISEASE AFTER HUMAN MARROW TRANSPLANTATION [J].
MCDONALD, GB ;
SHULMAN, HM ;
WOLFORD, JL ;
SPENCER, GD .
SEMINARS IN LIVER DISEASE, 1987, 7 (03) :210-229
[8]   The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: Current status and novel approaches [J].
Richardson, P ;
Guinan, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (03) :485-493
[9]   Silent presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection [J].
Sebagh, M ;
Debette, M ;
Samuel, D ;
Emile, JF ;
Falissard, B ;
Cailliez, V ;
Shouval, D ;
Bismuth, H ;
Reynès, M .
HEPATOLOGY, 1999, 30 (05) :1144-1150
[10]   Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation -: role of transjugular intrahepatic portosystemic shunt (TIPS) [J].
Zenz, T ;
Rössle, M ;
Bertz, H ;
Siegerstetter, V ;
Ochs, A ;
Finke, J .
LIVER, 2001, 21 (01) :31-36
1